Document is current
Any future updates will be listed below
-
Authors
Young, Mark G. https://orcid.org/0009-0001-4111-9329
Straub, Timothy J. https://orcid.org/0000-0001-5009-0778
Worby, Colin J. https://orcid.org/0000-0002-9132-7249
Metsky, Hayden C. https://orcid.org/0000-0002-8871-2349
Gnirke, Andreas https://orcid.org/0000-0001-5324-6387
Bronson, Ryan A.
van Dijk, Lucas R. https://orcid.org/0000-0002-7565-5859
Desjardins, Christopher A.
Matranga, Christian
Qu, James
Villicana, Jesús Bazan https://orcid.org/0000-0001-8724-3213
Azimzadeh, Philippe
Kau, Andrew https://orcid.org/0000-0002-9386-3766
Dodson, Karen W.
Schreiber, Henry L. IV https://orcid.org/0000-0002-4501-9886
Manson, Abigail L. https://orcid.org/0000-0002-3800-0714
Hultgren, Scott J. https://orcid.org/0000-0001-8785-564X
Earl, Ashlee M. https://orcid.org/0000-0001-7857-9145
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI110818, R01DK121822, R01AI165915, R01DK121822)
- License Information
-
More Information
Article History
Received: 23 July 2024
Accepted: 21 October 2024
First Online: 2 November 2024
Competing interests
: T.S.J., H.C.M., and A.M.E. are co-inventors on a patent application related to this study. H.C.M. is an employee of and holds equity in Inceptive Nucleics, Inc., and is a co-inventor of a patent related to work in this study (US11332783B2). T.S.J. is an employee and holds equity in Seres Therapeutics, Inc. The remaining authors declare no competing interests.
